Search

Faes Farma SA

Open

5.2 0.78

Overview

Share price change

24h

Current

Min

5.17

Max

5.23

Key metrics

By Trading Economics

Income

-4.4M

24M

Sales

154M

P/E

Sector Avg

15.059

90.422

Profit margin

15.516

Employees

1,775

EBITDA

33M

Dividends

By Dow Jones

Next Earnings

27 Feb 2026

Market Stats

By TradingEconomics

Market Cap

1.6B

Previous open

4.42

Previous close

5.2

Technical Score

By Trading Central

Confidence

Weak Bullish Evidence

Faes Farma SA Chart

Past performance is not a reliable indicator of future results.

Related News

29 Jan 2026, 22:31 UTC

Earnings

KLA Posts Higher 2Q Profit On Product and Services Sales Growth

29 Jan 2026, 22:05 UTC

Earnings

Stryker Logs Higher 4Q Profit On Sales Gains

29 Jan 2026, 21:54 UTC

Earnings

Visa 1Q Sales Climb on Strong Holiday Shopping -- Update

29 Jan 2026, 21:36 UTC

Earnings

Visa 1Q Sales Climb on Strong Holiday Shopping

29 Jan 2026, 23:57 UTC

Acquisitions, Mergers, Takeovers

Aluminum Corp. of China: to Hold 67% of Joint Venture With Rio Tinto

29 Jan 2026, 23:56 UTC

Acquisitions, Mergers, Takeovers

Aluminum Corp. of China: Deal Valued at Roughly BRL4.69 Billion

29 Jan 2026, 23:53 UTC

Acquisitions, Mergers, Takeovers

Aluminum Corp. of China Says It, Rio Tinto Propose to Buy 69% Stake in Companhia Brasileira de Aluminio S.A.

29 Jan 2026, 23:51 UTC

Earnings

Correction to Intel Earnings Article on Jan. 22 -- WSJ

29 Jan 2026, 23:49 UTC

Market Talk

Nikkei May Decline After Wall Street Tech Selloffs -- Market Talk

29 Jan 2026, 23:49 UTC

Market Talk

Gold Rises Amid Ongoing Iran Tensions -- Market Talk

29 Jan 2026, 23:47 UTC

Market Talk

Pro Medicus Looks Attractive Ahead of 1H Result -- Market Talk

29 Jan 2026, 23:35 UTC

Earnings

Apple Posts Blowout iPhone Sales on Surging China Demand -- 2nd Update

29 Jan 2026, 23:32 UTC

Market Talk

REA's 1H Result Could Jolt Share Price More Than Usual -- Market Talk

29 Jan 2026, 23:32 UTC

Market Talk

Global Equities Roundup: Market Talk

29 Jan 2026, 23:15 UTC

Market Talk
Earnings

Visa Says High Earners Still Lead Spending Growth -- Market Talk

29 Jan 2026, 22:27 UTC

Earnings

Sandisk Beats Earnings. The Stock Is Soaring. -- Barrons.com

29 Jan 2026, 22:27 UTC

Earnings

GE Vernova Gains After Earnings. Guidance Boost Was Enough to Lift the Stock. -- Barrons.com

29 Jan 2026, 22:12 UTC

Earnings

Visa Beats Expectations on Stronger Spending. The Stock Is Falling. -- Barrons.com

29 Jan 2026, 21:55 UTC

Earnings

Micron Stock Rises. Samsung Signals a 'Golden Era' for Memory Chips. -- Barrons.com

29 Jan 2026, 21:50 UTC

Market Talk
Earnings

Financial Services Roundup: Market Talk

29 Jan 2026, 21:50 UTC

Earnings

These Stocks Are Today's Movers: Microsoft, Meta, Tesla, Joby Aviation, SAP, Royal Caribbean, and More -- Barrons.com

29 Jan 2026, 21:50 UTC

Market Talk
Earnings

Health Care Roundup: Market Talk

29 Jan 2026, 21:50 UTC

Market Talk
Earnings

Auto & Transport Roundup: Market Talk

29 Jan 2026, 21:49 UTC

Earnings

Honeywell Delivers Solid Earnings Ahead of Its Corporate Breakup -- Barrons.com

29 Jan 2026, 21:46 UTC

Earnings

Apple Posts Blowout iPhone Sales on Surging China Demand -- Update

29 Jan 2026, 21:36 UTC

Earnings

Lockheed Martin Stock Jumps on Guidance and Government Missile Deal -- Barrons.com

29 Jan 2026, 21:32 UTC

Earnings

Visa Beats Expectations on Stronger Spending. The Stock Is Falling. -- Barrons.com

29 Jan 2026, 21:32 UTC

Earnings

Sandisk Beats Earnings. The Stock Is Soaring. -- Barrons.com

29 Jan 2026, 21:30 UTC

Earnings

Apple Posts Blowout IPhone Sales on Surging China Demand -- WSJ

29 Jan 2026, 21:30 UTC

Earnings

Apple 1Q Mac Rev $8.39B >AAPL

Faes Farma SA Forecast

Rating Consensus

By TipRanks

0 ratings

0

Buy

0

Hold

0

Sell

Technical Score

By Trading Central

4.15 / 4.275Support & Resistance

Short Term

Weak Bullish Evidence

Intermediate Term

Very Strong Bullish Evidence

Long Term

Strong Bullish Evidence

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Faes Farma SA

Faes Farma, S.A., researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials worldwide. It operates through Pharmaceutical and Healthcare Specialties; Animal Nutrition and Health; and Pharmaceutical Raw Materials segments. It offers products for various therapeutic areas. The company also provides animal nutrition and health products. Faes Farma, S.A. was incorporated in 1933 and is headquartered in Leioa, Spain.
help-icon Live chat